Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Block

Showing results (451-460 of 540) with videos related to

Pageof 54
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2013
Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammationWaldemar Kanczkowski, Vasileia-Ismini Alexaki, Nguyen Tran, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.
Hormones & Cancer|March 11, 2015
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2Paola Catanuto, Jun Tashiro, Ferenc G Rick, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersFerenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolithG N Sfakianakis, D J Cohen, R H Braunstein, et al.
The Pediatric Infectious Disease Journal|November 16, 2016
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US InfantsStanley L Block, Nicola P Klein, Kwabena Sarpong, et al.
Pediatrics|March 4, 2008
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of ageTerry Nolan, David I Bernstein, Stan L Block, et al.
Oncotarget|August 6, 2016
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathwaysTengjiao Cui, Joaquin J Jimenez, Norman L Block, et al.
Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Pageof 54

Showing results (451-460 of 540) with videos related to

Sort By:
Pageof 54
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2013
Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammationWaldemar Kanczkowski, Vasileia-Ismini Alexaki, Nguyen Tran, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.
Hormones & Cancer|March 11, 2015
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2Paola Catanuto, Jun Tashiro, Ferenc G Rick, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersFerenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolithG N Sfakianakis, D J Cohen, R H Braunstein, et al.
The Pediatric Infectious Disease Journal|November 16, 2016
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US InfantsStanley L Block, Nicola P Klein, Kwabena Sarpong, et al.
Pediatrics|March 4, 2008
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of ageTerry Nolan, David I Bernstein, Stan L Block, et al.
Oncotarget|August 6, 2016
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathwaysTengjiao Cui, Joaquin J Jimenez, Norman L Block, et al.
Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Pageof 54